The disclosure provides modified chloroquine compounds having single ring or fused ring moieties. Also provided are pharmaceutical compositions comprising such compounds, methods of using such compounds to inhibit or treat diseases or conditions caused by chloroquine-resistant (CQR) and chloroquine-sensitive (CqS) malaria parasites and other CQ-susceptible microorganisms, and processes and intermediates useful for preparing such compounds.
本公开提供了具有单环或融合环基团的改性
氯喹化合物。还提供了包括这种化合物的制药组合物,使用这种化合物抑制或治疗由
氯喹耐药(
CQR)和
氯喹敏感(
CQS)疟原虫和其他
CQ易感微
生物引起的疾病或病症的方法,以及用于制备这种化合物的过程和中间体。